经济观察网 天宇股份：卡格列净片获得药品注册证书

Core Viewpoint - Tianyu Co., Ltd. announced that its wholly-owned subsidiary, Zhejiang Norde Pharmaceutical Co., Ltd., has received the drug registration certificate for Canagliflozin from the National Medical Products Administration [1] Group 1: Product Approval - The drug Canagliflozin can be used in conjunction with Metformin to improve blood sugar control in adult patients with type 2 diabetes when Metformin alone is insufficient [1] - Canagliflozin can also be used in combination with Metformin and Sulfonylureas to enhance blood sugar control in adult patients with type 2 diabetes when the combination of these medications is not effective [1]